Abstract
Treatment of pregnant rats on gestation day 15 with methylazoxymethanol (MAM) leads to a marked microencephaly in the offspring with a considerable atrophy in cerebral cortex, hippocampus and striatum. The development of the astrocytic populations in these atrophic regions was studied by means of immunohistochemistry using an antiserum against glial fibrillary acidic protein (GFA). The distribution and density of GFA-positive structures were not notably altered in the parietal cortex, hippocampal formation and striatum after prenatal MAM-treatment as compared to control. Also the individual astrocytes were morphologically similar in experimental and control animals in all regions analyzed. We suggest that an adjustment of the astrocytic development has occurred in response to the changed neuronal environment. Alternatively, MAM-treatment may affect neuronal and glial precursor cells leading to a seemingly normal astrocytic cell density.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Developmental Neuroscience
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
